Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | NQO1 | P15559 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | ACHE | P22303 | 2/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HTR1B | P28222 | 5/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL151449 | 1.00 | MAPT (0.61) | MAPTNQO1CA12CA1CA2 | |
| SCHEMBL30373629 | 1.00 | MAPT (0.61) | MAPTNQO1CA12CA1CA2 | |
| Water SCHEMBL5028474 | 0.98 | MAPT (0.59) | MAPTNQO1CA12CA1CA2 | |
| Methane SCHEMBL28597903 | 0.98 | MAPT (0.59) | MAPTNQO1CA12CA1CA2 | |
| 1,2-Dimethoxybenzene SCHEMBL20581614 | 0.98 | CA12 (0.62) | MAPTNQO1CA12CA1CA2 | |
| SCHEMBL28523282 | 0.98 | MAPT (0.59) | MAPTNQO1CA12CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL229215 | 0.98 | MAPT (0.59) | MAPTNQO1CA12CA1CA2 | |
| SCHEMBL28602414 | 0.98 | MAPT (0.59) | MAPTNQO1CA12CA1CA2 | |
| Ethylene SCHEMBL28794169 | 0.95 | MAPT (0.57) | MAPTNQO1CA12CA1CA2 | |
| Nitrogen SCHEMBL9845797 | 0.95 | MAPT (0.57) | MAPTNQO1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119470678-A | Method for separating and measuring key intermediate and related impurities of non-steroidal anti-inflammatory drug by HPLC (high Performance liquid chromatography) | 上海博悦生物科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-115536721-B | Chiral interference spiroalkene molecular motor with photo-thermal dual responsiveness and preparation method thereof | 北京大学 | 2024-02-20 | — | — | CN | claimed |
| EP-3898588-B1 | DISUBSTITUTED ALKYNE DERIVATIVES | MERCK PATENT GMBH (DE) | 2023-01-11 | — | — | EP | claimed |
| EP-4007800-A1 | NANOSTRUCTURE INK COMPOSITIONS FOR INKJET PRINTING | Nanosys, Inc. (US) | 2022-06-08 | — | — | EP | claimed |
| EP-3956379-A1 | FORMULATION CONTAINING A CROSSLINKABLE POLYMER | Merck Patent GmbH (DE) | 2022-02-23 | — | — | EP | claimed |
| US-20250362609-A1 | SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING POLYFUNCTIONAL SULFONIC ACID | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-27 | — | — | US | disclosed |
| EP-4375342-B1 | INK COMPOSITION, ORGANIC MATERIAL LAYER COMPRISING SAME, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2025-11-26 | — | — | EP | disclosed |
| EP-4379007-B1 | INK COMPOSITION, ORGANIC MATERIAL LAYER COMPRISING SAME, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2025-11-26 | — | — | EP | disclosed |
| CN-119470678-A | Method for separating and measuring key intermediate and related impurities of non-steroidal anti-inflammatory drug by HPLC (high Performance liquid chromatography) | 上海博悦生物科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| WO-2025032039-A1 | PROCESS FOR THE PREPARATION OF AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2025-02-13 | — | — | WO | disclosed |
| US-12187681-B2 | Ion channel antagonists/blockers and uses thereof | SHANGHAI EAST HOSPITAL (CN) | 2025-01-07 | — | — | US | disclosed |
| WO-2024261190-A1 | ORGANIC THIN FILM TRANSISTORS | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2024-12-26 | — | — | WO | disclosed |
| WO-2022121224-A1 | ORGANOBORON-NITROGEN COMPOUND, MIXTURE, COMPOSITION AND ORGANIC ELECTRONIC DEVICE | 广州华睿光电材料有限公司 | 2022-06-16 | — | — | WO | disclosed |
| WO-2022122607-A1 | AN INK SYSTEM AND A METHOD FOR INKJET PRINTING | MERCK PATENT GMBH (DE) | 2022-06-16 | — | — | WO | disclosed |
| EP-4007800-A1 | NANOSTRUCTURE INK COMPOSITIONS FOR INKJET PRINTING | Nanosys, Inc. (US) | 2022-06-08 | — | — | EP | disclosed |
| US-20220165954-A1 | FORMULATION CONTAINING A CROSSLINKABLE POLYMER | MERCK PATENT GMBH (DE) | 2022-05-26 | — | — | US | disclosed |
| WO-2022066007-A1 | BACTERIAL UNSPECIFIC PEROXYGENASES (BUPO'S) AND METHODS AND USES THEREOF | GECCO BIOTECH B.V. (NL) | 2022-03-31 | — | — | WO | disclosed |
| WO-2022058019-A1 | MUGUET TYPE FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2022-03-24 | — | — | WO | disclosed |
| EP-3956379-A1 | FORMULATION CONTAINING A CROSSLINKABLE POLYMER | Merck Patent GmbH (DE) | 2022-02-23 | — | — | EP | disclosed |
| US-11246873-B2 | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12187681-B2 | Ion channel antagonists/blockers and uses thereof | CACNA1F, CACNA1S, CACNA1D | MAPT 2678/4885NQO1 1107/4885CA12 3005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.